CANBERRA, Australia, July 17 -- The Australian Competition and Consumer Commission issued the following news release:

* * *

Zoetis' acquisition of Neogen Genomics requires Phase 2 review

*

Zoetis Holdings LLC's (Zoetis) proposed acquisition of Neogen Corporation's global animal genomic testing business (Neogen Genomics) could substantially lessen competition and requires an in-depth Phase 2 assessment, the ACCC has decided.